{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:07:28Z","timestamp":1788001648551,"version":"build-2784847793"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.nbd.2023.106050","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T07:17:44Z","timestamp":1676877464000},"page":"106050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS\/FTD"],"prefix":"10.1016","volume":"179","author":[{"given":"Tariq","family":"Afroz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Audrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Dumayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Ziehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Egesipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lor\u00e8ne","family":"Mottier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monisha","family":"Ratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Havas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Ollier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Piorkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto B.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samjhana","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"St\u00f6hr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Bavdek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Eligert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Adolfsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia M.-Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Kosco-Vilbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Seredenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nbd.2023.106050_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-017-00062-0","article-title":"Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation","volume":"8","author":"Afroz","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.nbd.2023.106050_bb0010","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2023.106050_bb0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-021-04199-3","article-title":"Structure of pathological TDP-43 filaments from ALS with FTLD","volume":"601","author":"Arseni","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2023.106050_bb0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fnins.2019.00335","article-title":"The pathobiology of TDP-43 C-terminal fragments in ALS and FTLD","volume":"13","author":"Berning","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2023.106050_bb0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ana.23937","article-title":"Stages of pTDP-43 pathology in amyotrophic lateral sclerosis","volume":"74","author":"Brettschneider","year":"2013","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2023.106050_bb0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14728222.2018.1439923","article-title":"TDP-43 post-translational modifications in health and disease","volume":"22","author":"Buratti","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"7","key":"10.1016\/j.nbd.2023.106050_bb0035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41594-019-0248-4","article-title":"Cryo-EM structures of four polymorphic TDP-43 amyloid cores","volume":"26","author":"Cao","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.nbd.2023.106050_bb0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1742-2094-11-132","article-title":"Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2\/CCL2 signaling","volume":"11","author":"Cazareth","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"10.1016\/j.nbd.2023.106050_bb0045","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41374-019-0196-y","article-title":"Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy","volume":"99","author":"Chornenkyy","year":"2019","journal-title":"Lab. Investig."},{"key":"10.1016\/j.nbd.2023.106050_bb0050","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1038\/ncomms6845","article-title":"An acetylation switch controls TDP-43 function and aggregation propensity","volume":"6","author":"Cohen","year":"2015","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.nbd.2023.106050_bb0055","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.str.2016.07.007","article-title":"ALS mutations disrupt phase separation mediated by alpha-helical structure in the TDP-43 low-complexity C-terminal domain","volume":"24","author":"Conicella","year":"2016","journal-title":"Structure."},{"issue":"11","key":"10.1016\/j.nbd.2023.106050_bb0060","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1073\/pnas.1912055117","article-title":"TDP-43 alpha-helical structure tunes liquid-liquid phase separation and function","volume":"117","author":"Conicella","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.nbd.2023.106050_bb0065","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/s41598-021-81599-5","article-title":"Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis","volume":"11","author":"Conti","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.nbd.2023.106050_bb0070","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/nar\/gki312","article-title":"A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites","volume":"33","author":"Du","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.nbd.2023.106050_bb0075","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1083\/jcb.201504057","article-title":"TDP-43 is intercellularly transmitted across axon terminals","volume":"211","author":"Feiler","year":"2015","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.nbd.2023.106050_bb0080","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.1007\/s12035-018-0947-6","article-title":"Towards a TDP-43-based biomarker for ALS and FTLD","volume":"55","author":"Feneberg","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.nbd.2023.106050_bb0085","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neuron.2019.02.038","article-title":"Cytoplasmic TDP-43 De-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death","volume":"102","author":"Gasset-Rosa","year":"2019","journal-title":"Neuron."},{"issue":"13","key":"10.1016\/j.nbd.2023.106050_bb0090","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1073\/pnas.81.13.3998","article-title":"Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid","volume":"81","author":"Geysen","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.nbd.2023.106050_bb0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41594-018-0064-2","article-title":"Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation","volume":"25","author":"Guenther","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"5","key":"10.1016\/j.nbd.2023.106050_bb0100","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/brain\/awz078","article-title":"The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?","volume":"142","author":"Hergesheimer","year":"2019","journal-title":"Brain."},{"issue":"2","key":"10.1016\/j.nbd.2023.106050_bb0105","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1172\/JCI44867","article-title":"Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice","volume":"121","author":"Igaz","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2023.106050_bb0110","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jamaneurol.2020.1741","article-title":"Prevalence and clinical phenotype of quadruple misfolded proteins in older adults","volume":"(10),","author":"Karanth","year":"2020","journal-title":"JAMA Neurol.77"},{"issue":"5","key":"10.1016\/j.nbd.2023.106050_bb0115","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00401-019-02077-x","article-title":"The basis of clinicopathological heterogeneity in TDP-43 proteinopathy","volume":"138","author":"Kawakami","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.nbd.2023.106050_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126442","article-title":"Brain disposition of antibody-based therapeutics: dogma, approaches and perspectives","volume":"22","author":"Kouhi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2023.106050_bb0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41593-018-0294-y","article-title":"TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates","volume":"22","author":"Laferriere","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2023.106050_bb0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00401-017-1679-9","article-title":"Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration","volume":"134","author":"Lee","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2023.106050_bb0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/17482960903545334","article-title":"Guidelines for preclinical animal research in ALS\/MND: a consensus meeting","volume":"11","author":"Ludolph","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"issue":"3","key":"10.1016\/j.nbd.2023.106050_bb0140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12031-011-9551-1","article-title":"Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43","volume":"45","author":"Mackenzie","year":"2011","journal-title":"J. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2023.106050_bb0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/intimm\/dxu099","article-title":"Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective","volume":"27","author":"Malaspina","year":"2015","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.nbd.2023.106050_bb0150","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s12035-019-01810-7","article-title":"A role for SUMOylation in the formation and cellular localization of TDP-43 aggregates in amyotrophic lateral sclerosis","volume":"57","author":"Maurel","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.nbd.2023.106050_bb0155","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/NEN.0b013e3181ee7d85","article-title":"TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy","volume":"69","author":"McKee","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"23","key":"10.1016\/j.nbd.2023.106050_bb0160","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1073\/pnas.0703137104","article-title":"Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice","volume":"104","author":"Muhs","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.nbd.2023.106050_bb0165","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain."},{"issue":"1","key":"10.1016\/j.nbd.2023.106050_bb0170","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/ijms10010232","article-title":"Molecular neuropathology of TDP-43 proteinopathies","volume":"10","author":"Neumann","year":"2009","journal-title":"Int. J. Mol. Sci."},{"issue":"5796","key":"10.1016\/j.nbd.2023.106050_bb0175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science."},{"issue":"2","key":"10.1016\/j.nbd.2023.106050_bb0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00401-008-0477-9","article-title":"Phosphorylation of S409\/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies","volume":"117","author":"Neumann","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2023.106050_bb0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-3-030-51140-1_13","article-title":"Frontotemporal lobar degeneration TDP-43-immunoreactive pathological subtypes: clinical and mechanistic significance","volume":"1281","author":"Neumann","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.nbd.2023.106050_bb0190","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000937","article-title":"TDP-43-specific autoantibody decline in patients with amyotrophic lateral sclerosis","volume":"8","author":"Nielsen","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.nbd.2023.106050_bb0195","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.celrep.2013.06.007","article-title":"Prion-like properties of pathological TDP-43 aggregates from diseased brains","volume":"4","author":"Nonaka","year":"2013","journal-title":"Cell Rep."},{"issue":"6279","key":"10.1016\/j.nbd.2023.106050_bb0200","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.aaf1064","article-title":"C9orf72 is required for proper macrophage and microglial function in mice","volume":"351","author":"O\u2019Rourke","year":"2016","journal-title":"Science."},{"issue":"2","key":"10.1016\/j.nbd.2023.106050_bb0205","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuron.2017.05.037","article-title":"TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss","volume":"95","author":"Paolicelli","year":"2017","journal-title":"Neuron."},{"issue":"1","key":"10.1016\/j.nbd.2023.106050_bb0210","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1038\/s41467-018-06548-9","article-title":"Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo","volume":"9","author":"Porta","year":"2018","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.nbd.2023.106050_bb0215","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI123931","article-title":"Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology","volume":"129","author":"Pozzi","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.nbd.2023.106050_bb0220","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12974-022-02421-1","article-title":"ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression","volume":"19","author":"Quek","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"421","key":"10.1016\/j.nbd.2023.106050_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai7635","article-title":"A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants","volume":"9","author":"Ryan","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.nbd.2023.106050_bb0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mus.21386","article-title":"Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis","volume":"40","author":"Salajegheh","year":"2009","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.nbd.2023.106050_bb0235","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa142","article-title":"TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients","volume":"2","author":"Scialo","year":"2020","journal-title":"Brain Commun."},{"issue":"4","key":"10.1016\/j.nbd.2023.106050_bb0240","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1074\/mcp.M800390-MCP200","article-title":"Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains","volume":"9","author":"Seyfried","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"issue":"11","key":"10.1016\/j.nbd.2023.106050_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/v13112301","article-title":"TDP-43 and HERV-K envelope-specific immunogenic epitopes are recognized in ALS patients","volume":"13","author":"Simula","year":"2021","journal-title":"Viruses."},{"issue":"3","key":"10.1016\/j.nbd.2023.106050_bb0250","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41593-018-0083-7","article-title":"Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy","volume":"21","author":"Spiller","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2023.106050_bb0255","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1038\/s41598-018-24463-3","article-title":"Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals","volume":"8","author":"Tamaki","year":"2018","journal-title":"Sci. Rep."},{"issue":"Pt 11","key":"10.1016\/j.nbd.2023.106050_bb0260","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1093\/brain\/aws230","article-title":"Molecular analysis and biochemical classification of TDP-43 proteinopathy","volume":"135","author":"Tsuji","year":"2012","journal-title":"Brain."},{"issue":"5","key":"10.1016\/j.nbd.2023.106050_bb0265","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-015-1460-x","article-title":"Functional recovery in new mouse models of ALS\/FTLD after clearance of pathological cytoplasmic TDP-43","volume":"130","author":"Walker","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.nbd.2023.106050_bb0270","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201797452","article-title":"A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing","volume":"37","author":"Wang","year":"2018","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.nbd.2023.106050_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177181","article-title":"Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant","volume":"12","author":"Wobst","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.nbd.2023.106050_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109581","article-title":"Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTD","volume":"36","author":"Wu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2023.106050_bb0285","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/ncomms2303","article-title":"A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology","volume":"3","author":"Yamashita","year":"2012","journal-title":"Nat. Commun."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T11:32:03Z","timestamp":1716377523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996123000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":57,"alternative-id":["S0969996123000645"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106050","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS\/FTD","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106050"}}